CURMENTIN CV 325
TM Tablets combine Amoxycillin and Clavulanic Acid to provide enhanced antibacterial activity against resistant bacterial strains. Amoxycillin inhibits bacterial cell wall synthesis, while Clavulanic Acid acts as a beta-lactamase inhibitor, protecting Amoxycillin from enzymatic degradation. This combination extends the antibacterial spectrum and is commonly used in respiratory tract infections, ENT infections, urinary tract infections, and other bacterial conditions where resistance is a concern.
Composition
- Amoxycillin 250 mg
- Clavulanic Acid 125 mg
Key Features & Benefits
- Beta-Lactamase Inhibition: Protects Amoxycillin from bacterial resistance
- Extended Spectrum Coverage: Effective against a broader range of pathogens
- Dual-Action Mechanism: Combines antibiotic with enzyme inhibitor
- Effective in Resistant Infections: Suitable where standard therapy may fail
- Widely Prescribed: Trusted in clinical practice
Recommended Usage
- To be taken as prescribed by a healthcare professional
- Preferably taken after meals to improve tolerability
- Complete the full course as advised
Safety Information
- Not recommended in patients with hypersensitivity to penicillins or beta-lactam antibiotics
- Use cautiously in patients with liver or kidney disorders
- May cause gastrointestinal discomfort; take with food
- Do not exceed the recommended dose
Storage Instructions
- Store in a cool, dry place
- Protect from moisture and direct sunlight
- Keep out of reach of children
